Detalhe da pesquisa
1.
Proof of concept of triple COMBI therapy to prohibit MPN progression to AML.
Br J Haematol
; 204(1): 16-18, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957927
2.
COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort study.
Ann Hematol
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38634916
3.
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms.
Eur J Haematol
; 112(5): 776-787, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38226781
4.
Whole blood transcriptional profiling reveals highly deregulated atherosclerosis genes in Philadelphia-chromosome negative myeloproliferative neoplasms.
Eur J Haematol
; 111(5): 805-814, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37640394
5.
Mathematical modelling of stem and progenitor cell dynamics during ruxolitinib treatment of patients with myeloproliferative neoplasms.
Front Immunol
; 15: 1384509, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38846951
6.
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study.
Blood Cancer J
; 14(1): 28, 2024 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331919
7.
JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study.
Blood Adv
; 7(19): 5825-5834, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37522722
8.
A novel integrated biomarker index for the assessment of hematological responses in MPNs during treatment with hydroxyurea and interferon-alpha2.
Cancer Med
; 12(4): 4218-4226, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36254099
9.
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms.
Cancers (Basel)
; 15(17)2023 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37686599
10.
The gut microbiota in patients with polycythemia vera is distinct from that of healthy controls and varies by treatment.
Blood Adv
; 7(13): 3326-3337, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260736
11.
Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis.
Front Oncol
; 13: 1176173, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37223675
12.
Pronounced gut microbiota signatures in patients with JAK2V617F-positive essential thrombocythemia.
Microbiol Spectr
; : e0066223, 2023 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37695126
13.
Recombinant Interferon-ß in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives.
Cancers (Basel)
; 14(22)2022 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36428587
14.
Interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms favorably impacts deregulation of oxidative stress genes and antioxidative defense mechanisms.
PLoS One
; 17(6): e0270669, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35771847
15.
[Elevated blood cell counts and vascular disease with the myeloproliferative neoplasms as model diseases].
Ugeskr Laeger
; 183(42)2021 10 18.
Artigo
em Dinamarquês
| MEDLINE | ID: mdl-34709157
16.
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties.
Blood Adv
; 8(3): 681-682, 2024 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38134296